Development and characterization of liposomal drug delivery system for Nimesulide

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 4, 2010, Pages 87-89

  Kumar, Ajay ^a   Badde, Shital ^a   Kamble, Ravindra ^a   Pokharkar, Varsha B ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Cholesterol (CH); Dipamitoyl phosphatidyl choline (DPPC); Multilamillar vesicles (MLV); Nimesulide; Small unilamillar vesicles (SUV); Stearic acid

Indexed keywords

ALCOHOL; CHOLESTEROL; DRUG CARRIER; LIPID; LIPOSOME; NIMESULIDE; STEARIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; EVAPORATION; INTERMETHOD COMPARISON; LIPOSOMAL DELIVERY; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 78649749937     PISSN: 09751491     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bangham AD, Standish MM and Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-252.
2. Fielding MR. Liposomal drug delivery: advantages and limitations from a clinical pharmacokinetics and therapeutic perspective. Clin Pharmacokinetics 1991; 21: 155-164.
3. Akbarieh M, Besner JG, Galal A and Tawashi R. Liposomal delivery system for the targeting and controlled release of praziquantel. Drug Dev Ind Pharm 1992; 18: 303-317.
4. Lidgate DM, Felgner PL, Fleitman JS, Whatley J and Fu RC. In- vitro and in-vivo studies evaluating a liposome system for drug solubilisation. Pharm Res 1988; 5: 759-764.
5. Weiner N, Martin F and Riox M. Liposomes as drug delivery system. Drug Dev Ind Pharm 1989; 15(10): 1523-1554.
6. Lopez-Berestein, G. and Fidler, I.J. Liposomes in the Therapy of lnfectious Diseases and Cancer. Alan R. Liss; New York: 1989.
7. Yimei Jia, Helene Joly, Abdelwahab Omri. Liposomes as a carrier for gentamicin delivery: Development and evaluation of the physicochemical properties. International Journal of Pharmaceutics 2008; 359: 254-263.
8. Hwang, K.J. In Liposomes: from Biophysics to Therapeutics. Marcel Dekker Inc. New York: 1987; 109-110.
9. Taylor, K.M.G., Taylor, G., Kellaway, I.W. and Stevens, J. Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes. Int J Pharm 1990; 58: 49-55.
10. Stebelska K. The Effect of PS Content on the Ability of Natural Membranes to Fuse with Positively Charged Liposomes and Lipoplexes. J Membrane Biol 2005; 206: 203-214.
11. Gregoriadis G. Liposomes as Drug Carriers: Recent Trends and Progress. John Wiley and Sons. New York: 1988; 663-677.
12. Lian, T., Ho, R.J.Y. Trends and developments in liposome drug delivery systems. J Pharm Sci 2001; 90: 667-680.
13. Mahesh N., Varsha B. Pokharkar. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. International Journal of Pharmaceutics 2006; 320: 37-44.
14. Gomez-Hens, Analytical methods for the control of liposomal delivery systems. Trends in Analytical Chemistry 2006; 25: 2.
15. Maitani Y, Igarashi S. Cationic liposome (DC-Chol/DOPE = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. International Journal of Pharmaceutics 2007; 342: 33-39.
16. Sabin J. Size and stability of liposomes: A possible role of hydration and osmotic forces. Eur Phys J E 2006; 20: 401-408.
17. Marija Glavas-Dodov, 5-Fluorouracil in topical liposome gels for anticancer treatment - Formulation and evaluation. Acta Pharm 2003; 53: 241-250.
18. Omaima N. El-Gazayerly, Ahmed H. Hikal, Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. International Journal of Pharmaceutics 1997; 158: 121-127.